SCHEMBL21348419

SCHEMBL21348419

CC[C@@H]1O[C@H](CC)[C@@H](F)[C@H]1O

nearest known ligand 0.44

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
▸ OGA O60502 12/20 0.44
▸ HEXB P07686 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21349073 1.00 OGA (0.44) OGAHEXB
SCHEMBL21348403 1.00 OGA (0.44) OGAHEXB
SCHEMBL12417938 0.87 OGA (0.36) OGA
SCHEMBL14556012 0.84 OGA (0.42) OGAHEXB
SCHEMBL10026361 0.83 OGA (0.42) OGA
SCHEMBL20280297 0.81 OGA (0.41) OGA
SCHEMBL19938156 0.81 OGA (0.41) OGA
SCHEMBL14447610 0.81 OGA (0.41) OGA
SCHEMBL12972236 0.81 OGA (0.41) OGA
SCHEMBL13575271 0.81 OGA (0.41) OGA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020163673-A1 INHIBITORS OF ADENYLATE-FORMING ENZYME MENE MEMORIAL SLOAN-KETTERING CANCER CENTER (US) 2020-08-13 — — WO disclosed
WO-2019173682-A1 PARENTERALLY ADMINISTERED IMMUNE ENHANCING DRUGS ARCUS BIOSCIENCES, INC. (US) 2019-09-12 — — WO disclosed
Send feedback